{
    "eid": "2-s2.0-85050512776",
    "title": "Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations",
    "cover-date": "2018-10-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "Amphotericin B",
        "hemolytic; antifungal",
        "nanostructured lipid carriers; aggregates",
        "solid lipid nanoparticles"
    ],
    "authors": [
        "Phatsawee Jansook",
        "Wiwat Pichayakorn",
        "Garnpimol C. Ritthidej"
    ],
    "citedby-count": 32,
    "ref-count": 46,
    "ref-list": [
        "Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies",
        "Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art",
        "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations",
        "Solid lipid nanoparticles for parenteral drug delivery",
        "Solid lipid nanoparticles: Production, characterization and applications",
        "Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure",
        "Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems",
        "Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye\u2013Part II - Ocular drug-loaded lipid nanoparticles",
        "Leishmaniasis: drugs in the clinic, resistance and new developments",
        "Amphotericin B formulations and drug targeting",
        "PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome",
        "The global burden of fungal diseases",
        "Amphotericin B lipid preparations: what are the differences?",
        "Bovine serum albumin nanoparticles containing amphotericin B: Characterization, cytotoxicity and in vitro antifungal evaluation",
        "Theoretical study of the self-association of amphotericin B",
        "The effect of serum albumin on the aggregation state and toxicity of amphotericin B",
        "New lipid formulation of amphotericin B: spectral and microscopic analysis",
        "Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin B",
        "Amphotericin B loaded SLN prepared with the coacervation technique",
        "A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats",
        "Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module",
        "Stability and transdermal absorption of topical amphotericin B liposome formulations",
        "Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B",
        "Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles",
        "Standardization of antifungal susceptibility testing and clinical relevance",
        "Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard",
        "In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs",
        "Comparison of the minimum fungicidal concentration of amphotericin B determined in filamentous fungi by macrodilution and microdilution methods",
        "Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol",
        "The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B",
        "Topical amphotericin B solid lipid nanoparticles: design and development",
        "Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits",
        "Biodegradable functional polycarbonate micelles for controlled release of amphotericin B",
        "Development of polyion complex micelles for encapsulating and delivering amphotericin B",
        "Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization",
        "Aggregation of polyene antibiotics as studied by electronic absorption and circular dichroism spectroscopies",
        "Poly(\u03b5-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity",
        "Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles",
        "Amphotericin B/emulsion admixture interactions: An approach concerning the reduction of amphotericin B toxicity",
        "Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles",
        "Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B",
        "Carrier effects on biological activity of amphotericin B",
        "Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B",
        "Preparation by spray drying of amphotericin B-phospholipid composite particles and their anticellular activity",
        "Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant",
        "The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-l-aspartamide)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}